i cut-n-pasted this from an earlier post by me (I used a 235 man--for you the numbers are much much worse)to demonstrate that the line between what dose will work and what dose will likely cause permanent damage or kill you is too close to even consider taking. period.
while asprin can be fatal in doses over 55,000 mg (88x-166x therapeutic dose) (assume 235lb man)
dnp can be fatal at 1g-3g* ( <1x-7x doses taken by bbs)
with a possibilty that the line between fat loss and death is less than 1x the dose taken and the product produced by an UG, how can that be even considered safe to take or being able to used in a safe manner by any stretch? esp when ........
the signs and symptoms of acute poisoning are the same as expected for fat loss**
and btw, don't take asprin while on dnp***
*The fatal dose in adults is about 1 to 3 g by mouth, and 3 g has proved fatal even in divided doses over a period of 5 days. [Gosselin, R.E., R.P. Smith, H.C. Hodge. Clinical Toxicology of Commercial Products. 5th ed. Baltimore: Williams and Wilkins, 1984., p. III-157; The acute fatal dose of dinitrophenol /SRP: Unspecified mixture of isomers/ is approximately 1 g.[Dreisbach, R.H. Handbook of Poisoning. 11th ed. Los Altos, CA: Lange Medical Publications. 1983., p. 127}
**Signs and symptoms of acute poisoning in human beings include nausea, restlessness, flushed skin, sweating, rapid respiration, tachycardia, fever, cyanosis, and finally, collapse and coma. The illness runs a rapid course; death or recovery occurs within 24 to 48 hours. If production of heat exceeds the capacity for its dissipation, fatal hyperthermia may result. Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 1691
***"Salicylates, which contain a phenolic group, must be avoided during treatment for exposure to dinitrophenols." [Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 1691]